ActiveMax® Human IL-6 Protein, Tag Free

Source : 

ActiveMax® Human IL-6, Tag Free (IL6-H4218) is expressed from human 293 cells (HEK293). It contains AA Val 30 - Met 212 (Accession # NP_000591).

 

Molecule : IL-6

 

Synonyms : IL6,Interleukin-6,BSF2,HSF,IFNB2

 

Format : Powder

 

Category : ActiveMax® Cytokines

 

Accession : NP_000591

 

Storage : -20℃

 

Shipping condition : Powder,RT

 

Molecular Weight : 20.8 kDa

 

Characteristics :

This protein carries no "tag". The protein has a calculated MW of 20.8 kDa. The protein migrates as 25-32 kDa under reducing (R) condition (SDS-PAGE) due to different glycosylation.

 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.

 

Buffer : PBS, pH7.4

 

Description :

Interleukin 6 (IL-6) is also known as HGF, BSF2,HSF, IFNB2 and IL-6, originally identified as a B cell differentiation factor, is a multifunctional cytokine that regulates immune responses, hematopoiesis, acute phase responses, and inflammatory reactions.It is secreted by T cells, macrophages , monocytes, fibroblasts,endothelial cells,et.al. to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation. Interleukin 6 has been shown to interact with interleukin-6 receptor and glycoprotein. IL-6 is relevant to many disease processes such as diabetes,atherosclerosis, depression,Alzheimer's Disease,systemic,lupus erythematosus,prostate cancer and rheumatoid arthritis. Advanced/metastatic cancer patients have higher levels of IL-6 in their blood.Hence there is an interest in developing anti-IL-6 agents as therapy against many of these diseases.

 

References :

(1) Ferguson-Smith AC,et.al. 1988, Genomics 2 (3): 203–8.
(2) Schwantner A,et. al. 2004, J. Biol. Chem. 279 (1): 571–6.
(3) Schuster B,et. al. 2003, J. Biol. Chem. 278 (11): 9528–35.
(4) Taga T,et al.1989, Cell 58 (3): 573–81.